A live virus vaccine contains a live, weakened (attenuated) virus that helps your body develop an immune response without you developing symptoms of the disease it is intended to prevent. Examples ...
Japan’s MHLW grants expanded indication approval to GSK’s RSV vaccine, Arexvy for adults aged 50-59 at increased risk of severe RSV disease: London, UK Saturday, November 23, ...
Phase 1 trial demonstrates safety and effectiveness of neoantigen DNA vaccines in triple-negative breast cancer, achieving 87.5% recurrence-free survival at 36 months.